If you suspect you've fallen for a digital payment app scam, contact the app and your financial institution immediately. There's no guarantee you can reclaim your stolen funds, but your bank may be ...

The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...

That’s why, as a 2016 Vox investigation found, there are many reports of vitamins and supplements containing ingredients that ...

15 analysts have expressed a variety of opinions on Hims & Hers Health HIMS over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes their ...

The knockoff surge was led by Hims & Hers Health, the telehealth firm that began selling the drugs last spring.

Investing.com -- Hims&Hers Health shares are down over 8% premarket Thursday after a federal judge ruled in favor of the FDA in the tirzepatide compounding case. Bank of America wrote in a note ...

Investing.com -- Hims & Hers Health shares are down over 8% premarket Thursday after a federal judge ruled in favor of the FDA in the tirzepatide compounding case. Bank of America wrote in a ...

The stock is down 10.5% as 2 p.m. ET on Friday, while the stock is still up 224% in the last year. Here's why Hims & Hers stock fell this week. Where to invest $1,000 right now? Our analyst team ...

Hims & Hers reported its Q4 earnings this week. The company is growing quickly but faces a potential legal threat to its weight loss drug program. It is guiding for margin expansion and fast ...

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders should know. We noticed this today when the trades showed up on publicly available ...